Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis

American Journal of Nephrology

Volumn 21, Issue 2, 2001, Pages 134-140

  Sinniah, Raja ^a,b   Gan, Hwa Chau ^a   Yoon, Kam Hon ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Antiphospholipid antibody syndrome, primary; Henoch Sch nlein syndrome; IgA nephropathy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; AUTOANTIBODY; CORTICOSTEROID; FIBRINOGEN; GLIBENCLAMIDE; HYDROCORTISONE; IMMUNOGLOBULIN A; METFORMIN; PREDNISOLONE;

ABOVE KNEE AMPUTATION; ACUTE KIDNEY FAILURE; ADULT; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FOCAL GLOMERULONEPHRITIS; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SKIN BIOPSY; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; FIBRINOGEN; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY; MALE;

EID: 0035010908     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046236     Document Type: Article

References (56)

1. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GR: The 'primary' antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989;68:366-374.
2. Lockshin MD: Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994;20: 45-59.
3. Lockshin MD: Answers to the antiphospholipid antibody syndrome. N Engl J Med 1995;332: 1025-1027.
4. Cervera R, Asherson RA, Lie JT: Clinicopathological correlations of the antiphospholipid syndrome. Semin Arthritis Rheum 1995;24: 262-272.
5. Lechner K, Pabinger-Fasching I: Lupus antico-agulants and thrombosis: A study of 25 cases and review of the literature. Haemostasis 1985; 15:254-262.
6. Conley CL, Hartman RC: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952;31:621-622.
7. Espinoza LR, Hartman RC: Significance of the lupus anticoagulant. Am J Hematol 1986;22: 331-337.
8. Sokunbi DOB, Miller F, Wadhwa NK, Nord EP: Reversible renal failure in the primary antiphospholipid syndrome - a report of two cases. J Am Soc Nephrol 1993;3:28-35.
9. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO: Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987;123:596-600.
10. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW: Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-419.
11. Garber ME, Mohr BW, Calabrese LH: Henoch-Schönlein purpura associated with anti-RO (SSA) and antiphospholipid antibody syndrome. J Rheumatol 1993;20:1964-1966.
12. Triplett DA, Brandt JT, Musgrave KA, Orr CA: The relationship between lupus anticoagulants and antibodies to phospholipids. JAMA 1988;259:550-554.
13. Alving BM, Barr CF, Tang DB: Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times. Am J Med 1990;85:112-116.
14. Alarcon-Segovia D, Delèze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon S: Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-365.
15. Bowie EJW, Thompson JH, Pascuzzi CA, et al: Thrombosis in systemic lupus erythematosus despite circulating anticoagulant. J Lab Clin Med 1963;62:416-430.
16. Love PE, Santoro SA: Antiphospholipid antibodies, anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-689.
17. Petri M: Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 1997;81:151-177.
18. Alarcon-Segovia D, Sanchez-Guerrero J: Primary antiphospholipid antibody syndrome. J Rheumatol 1986;16:482-489.
19. Hughson M, McCarty G, Brumbach R: Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol 1995;26:716-724.
20. Kanadiah DA, Sheng YH, Krilis SA: Beta-2-glycoprotein 1: Target antigen for autoantibodies in the 'antiphospholipid syndrome'. Lupus 1996;5:385-385.
21. Courtecuisse V, Habib R, Mounier C: Nonlethal hemolytic and uraemic syndromes in children - an electron microscopic study of renal biopsies in 6 cases. Exp Mol Pathol 1967; 7:327-347.
22. Kincaid-Smith P, Fairley KF, Kloss M: Lupus anticoagulant associated with renal thrombotic microangiography and pregnancy-related renal failure. Q J Med 1988;69:795-815.
23. Kon SP, Kwan JTC, Raftery MJ: Reversible renal failure due to the antiphospholipid antibody syndrome, pre-eclampsia and renal thrombotic microangiopathy. Clin Nephrol 1995;44:271-273.
24. D'Agati V, Kunis C, Williams G, Appel G: Anticardiolipin antibody and renal disease: A report of three cases. J Am Soc Nephrol 1990;1: 777-784.
25. Yoshida A, Morozumi K, Takeda A, Koyama K, Ideura T, Oikawa T: Nephropathy in patients with primary antiphospholipid antibody syndrome. Jpn J Nephrol 1994;36:158-162.
26. Tsuzuki T, Tomita M, Murakami K, Kawashima S: A case of anti-phospholipid antibody syndrome associated with typical mesangiolysis. Jpn J Nephrol 1994;36:1046-1051.
27. Nakano H, Tuchida H, Hamaguchi K, Wakabayashi Y, Nishimura M, Suzuki S, Miura Y, Watanabe S, Yamada K, Shibasaki T, Sakai O: A case of primary antiphospholipid antibody syndrome with severe nephritic syndrome showing remarkable endothelial cell damage in the capillary lumen. Jpn J Nephrol 1997;39: 431-437.
28. Sakaguchi S, Kitazawa K, Watanabe M, Mukai K, Totsuka D, Shibata T, Sugisaki T: A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy. Am J Nephrol 1999;19:594-598.
29. Seshan SV, D'Agati VD, Appel GA, Churg J: Renal Disease: Classification and Atlas of Tubulo-Interstitial and Vascular Diseases. Baltimore, Williams & Wilkins, 1999, pp 347-349.
30. Ginsberg JS, Demers C, Brill-Edwards P, Johnston M, Bona R, Burrows RF, Weitz J, Denburg JA: Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: Evidence for a prothrombotic state. Blood 1993; 81:2958-2963.
31. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV: The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-997.
32. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF: Lupus anticoagulant IgG's (EA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-632.
33. Delèze M, Oria CV, Alarcon-Segovia D: Occurrence of both hemolytic anaemia and thrombocytopenic purpura (Evan's syndrome) in systemic lupus erythematosus: Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15:611-615.
34. Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y: Clinical significance of immunoglobulin A antiphospholipid antibodies: Possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998;25:1730-1736.
35. Carreras LO, Vermylen J, Spitz B, Van Asschc A: Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981; 88:890-894.
36. Kelton JG, Moore J, Santos A, Sheridan D: Detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. Ann Intern Med 1984;101:589-593.
37. Inbar O, Blank M, Faden D, Tincani A, Lorber M, Shoenfeld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin. Am J Obstet Gynecol 1993;169:423-426.
38. Picrangeli SS, Barker JH, Stikovac D, Ackerman D, Anderson G, Barquinero J, Acland R, Harris EN: Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994;71:670-674.
39. Cervera R, Khamashta MA, Font J. Ramirez G, D'Cruz D, Montalban J, Lopez-Soto A, Asherson RA, Ingelmo M, Hughes GR: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991;11:1-6.
40. Del Papa N, Meroni PL, Tincani A, Harris EM, Pierangeli SS, Barcellini W, Borghi MO, Balestricri G, Zanussi C: Relationship between antiphospholipid and anti-endothelial cell antibodies: Further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992;10:37-42.
41. Silva MF, Pimentel FL, Faria MS, Carvalho-Costa AE, Nuñes JPE: IgA nephropathy and antiphospholipid syndrome. Nephron 1999;83: 95-96.
42. Sinniah R, Pwee HS, Lim CH: Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination. Clin Nephrol 1976;5:216-228.
43. Sinniah R, Law CH, Pwee HS: Glomerular lesions in patients with asymptomatic persistent and orthostatic proteinuria discovered on routine medical examination. Clin Nephrol 1977;7:1-14.
44. Sinniah R: IgA mesangial nephropathy: Berger's disease. Am J Nephrol 1985;5:73-83.
45. Sinniah R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 1983;36:276-279.
46. Sinniah R, Javier AR, Ku G: The pathology of mesangial IgA nephritis with clinical correlation. Histopathology 1981;5:469-490.
47. Sinniah R, Churg J: Effect of IgA deposits on the glomerular mesangium in Berger's disease Ultrastruct Pathol 1983;4:9-22.
48. Sinniah R, Feng PH, Chen BTM: Henoch-Schönlein syndrome: A clinical and morphological study of renal biopsies. Clin Nephrol 1978;9:219-228.
49. Levy M, Broyer M, Habib R: Pathology and immunopathology of Schönlein-Henoch nephritis: in Kincaid-Smith P, D'Apice D, Atkin RC (eds): Progress in Glomerulonephritis. New York, Wiley, 1979. pp 261-282.
50. de la Faille-Kuyper B, Kater L, Kuijten RH, Kooikcr CJ, Wagenaar SS, van der Zouwen P, Meers EJD: Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int 1976;9:424-429.
51. Ku G, Sinniah R, Scah PP, Loke GKE, Lau YK, Chan HL, Tay L, Khoo OT: Simultaneous analysis of renal biopsy, immunochemistry and immunofluorescent studies of clinically normal skin in glomerulonephritis. J Med Assoc Thai 1978:61(suppl 1):3-9.
52. Callard P, Feldmann G, Prandi P, Belair MF, Maudet C, Weiss Y, Druet P, Benhamou JP, Bariety J: Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol 1975;80:329-337.
53. Sinniah R: Heterogenous IgA glomerulonephropathy in liver cirrhosis. Histopathology 1984;8:947-962.
54. Sinniah R: Mucin secreting cancer with mesangial IgA deposits. Pathology 1982;14:303-308.
55. Liebergen FJHM, Assman KJM, Koene RAP, van de Putte LBA: IgA nephropathy and ankylosing spondylitis. Kidney Int 1983;24:408.
56. Hurault de Ligny B, Sirbat D, Bené MC, Faure G, Kessler M: Frequent association of scleritis and IgA nephropathy or glomerulonephritis with mesangial C3 deposits. Kidney Int 1983; 24:405-407.